A notable finding in this study is the capacity of EphrinB2-Fc-His and Fc-TNYL-RAW-GS to decrease local tumor growth and the incidence of lung metastases in a preclinical model of HNSCC. The gene discussed is EFNB2; the disease is head and neck squamous cell carcinoma.